Stocks and Investing Stocks and Investing
Wed, May 6, 2020
[ 12:00 AM ] - WOPRAI
Toni Kaplan Maintained (ARMK) at Hold with Decreased Target to $25 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Andrew Wittmann Maintained (ARMK) at Hold with Decreased Target to $24 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Matthew McClintock Upgraded (AEO) to Buy and Held Target at $10 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Koosh Patel Maintained (AER) at Strong Buy with Decreased Target to $44 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Nathan Weinstein Maintained (ACST) at Strong Buy with Decreased Target to $103 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Joseph Spak Upgraded (ADNT) to Buy and Increased Target to $20 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Dan Levy Maintained (ADNT) at Buy with Increased Target to $22 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Alan Carr Maintained (ALNY) at Strong Buy with Increased Target to $160 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Tavis McCourt Maintained (ALRM) at Strong Buy with Decreased Target to $55 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Jamie Cook Maintained (ALSN) at Buy with Increased Target to $47 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Joshua Pokrzywinski Maintained (AME) at Buy with Increased Target to $90 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Richard Eastman Maintained (AME) at Hold with Increased Target to $84 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Thomas Yeh Maintained (AMCX) at Hold with Decreased Target to $25 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
David Bishop Downgraded (BHLB) to Hold and Decreased Target to $14 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
David Lewis Maintained (AXNX) at Buy with Increased Target to $42 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
David Toung Maintained (AZN) at Strong Buy with Increased Target to $60 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Jim Suva Maintained (ANET) at Strong Buy with Increased Target to $61 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Jeff Kvaal Maintained (ANET) at Hold with Increased Target to $48 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Tal Liani Reiterated (ANET) at Hold with Increased Target to $58 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Sami Badri Maintained (ANET) at Hold with Decreased Target to $37 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
James Faucette Maintained (ANET) at Hold with Increased Target to $51 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Michael Halloran Maintained (AOS) at Hold with Increased Target to $45 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Matthew Miller Maintained (AOS) at Strong Sell with Decreased Target to $32 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Nathan Jones Maintained (AOS) at Strong Buy with Increased Target to $47 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Craig Ellis Maintained (AOSL) at Hold with Increased Target to $11 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Ella Ji Maintained (AMZN) at Hold on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Ann Duignan Maintained (AGCO) at Hold with Decreased Target to $57 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Adam Klauber Downgraded (AIG) to Hold on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Matt Howlett Maintained (AJX) at Strong Buy with Decreased Target to $12 on, May 6th, 2020
[ 12:00 AM ] - WOPRAI
Difei Yang Maintained (AKBA) at Strong Buy with Increased Target to $17 on, May 6th, 2020

Difei Yang Maintained (AKBA) at Strong Buy with Increased Target to $17 on, May 6th, 2020


Published on 2024-10-27 05:29:24 - WOPRAI, Difei Yang
  Print publication without navigation


Difei Yang of Mizuho, Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Increased Target from $15 to $17 on, May 6th, 2020.

Difei has made no other calls on AKBA in the last 4 months.



There is 1 other peer that has a rating on AKBA. Out of the 1 peers that are also analyzing AKBA, 0 agree with Difei's Rating of Hold.



This is the rating of the analyst that currently disagrees with Difei

  • Chad Messer of "Needham" Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 5th, 2020
Contributing Sources